EUCAST News
Here you can find the latest news and updates from EUCAST.
Updated version of "Guidance on intravenous use of fosfomycin"
The guidance document on "Intravenous use of fosfomycin" updated. See guidance documents. [more]
Aztreonam-avibactam and cefepime-enmetazobactam breakpoints published
MIC and zone diameter breakpoints for aztreonam-avibactam and cefepime-enmetazobactam are now available as addenda to the clinical breakpoint table 14.0. The breakpoints will be integrated in the regular breakpoint table...[more]
General Committee 2024 meeting - minutes published
The EUCAST General Committee meeting 2024 was held in Barcelona during ESCMID Global. The minutes are now available. [more]
Proposed change of breakpoints for aminopenicillins in enterococci
Proposed change of breakpoints for aminopenicillins in enterococci (consultation period 7 May - 14 June, 2024). Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the...[more]
Consultation: benzylpenicillin breakpoints for S.pneumoniae and Viridans group streptococci
EUCAST consultation(3 May - 14 June) on breakpoints for Streptococcus pneumoniae and viridans group streptococci. [more]
Aztreonam-avibactam and cefepime-enmetazobactam now available.
Aztreonam-avibactamhas now obtained regulatory approval and breakpoints from EMA and EUCAST for Enterobacterales. These are S≤4, R>4 mg/L.Disk diffusion criteria and QC targets and ranges will be published...[more]
